News
New recommendations suggest holding back on SGLT2 inhibitors and GLP-1s among those at a lower risk for cardiovascular or ...
If approved, AbbVie's Rinvoq could be set to dominate the alopecia market after exhibiting better efficacy than main ...
According to a report by the Financial Times, Morgan & Morgan, a law firm, revealed it had filed a case on behalf of a ...
Sales of the weight loss injection Wegovy have skyrocketed in the UK after the manufacturer of rival drug Mounjaro announced ...
CheqUp said it had experienced a spike in interest from consumers wanting to switch or begin taking the medication.
GLP-1 drugs for diabetes and weight loss may influence patients’ cancer risk, usually lowering it but sometimes possibly increasing it, new findings suggest.
Eli Lilly and Company faces a pivotal period with the upcoming retirement of Anne White, a key neuroscience leader set for ...
J&J said on Thursday it has reached a 10-year agreement with Tokyo-based contract drug developer Fujifilm Biotechnologies for ...
This is all you need to know about the new weight loss jab 'Reta' that's said to be 3 times stronger than Ozempic.
Johnson & Johnson announces a $2 billion North Carolina manufacturing expansion as part of a broader U.S. onshore ...
This week on "The Readout LOUD," we discuss Viking Therapeutics' obesity flop and dish on the growing "pharm to table" movement.
20h
TipRanks on MSNEli Lilly’s Promising Cancer Therapy Study: A Potential Game-Changer?
Eli Lilly And Company (($LLY)) announced an update on their ongoing clinical study. Study Overview: Eli Lilly and Company is conducting a clinical ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results